Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate - Wikidata - wikimedia - TriplyDB

Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate

Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate

http://www.wikidata.org/entity/Q36245717

about

Gene expression pattern of cells from inflamed and normal areas of osteoarthritis synovial membrane Chondroitin and glucosamine in the management of osteoarthritis: an update.TNFSF15 Modulates Neovascularization and Inflammation Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.Targeting the synovial angiogenesis as a novel treatment approach to osteoarthritis.Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis.A Three-Dimensional Chondrocyte-Macrophage Coculture System to Probe Inflammation in Experimental Osteoarthritis.Management of knee osteoarthritis. Current status and future trends.Chondroitin Sulfate Inhibits Monocyte Chemoattractant Protein-1 Release From 3T3-L1 Adipocytes: A New Treatment Opportunity for Obesity-Related Inflammation?Osteoarthritis synovial fluid activates pro-inflammatory cytokines in primary human chondrocytes.Exosomes from IL-1β stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes.Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties.Vascular endothelial growth factor expression and their action in the synovial membranes of patients with painful knee osteoarthritis.

P2860

Q33661869-6D5A17FC-7F40-45BD-99FD-00E3BB86ACFD Q34655436-760CAF97-F4A3-4684-BB26-886E51A5D8A0 Q36284920-B3C8CA27-7F1D-4578-8FE3-D228951E7EBB Q36890872-4CFFDD02-8F29-4286-AE2C-39552765ED11 Q38184546-9F49CD12-75A3-4D93-B91C-07718C8AFF66 Q38287819-FD02FC64-6FCD-4F02-B9F6-DF15F663FDD6 Q38812043-DD498FCC-BE15-470F-94BA-319A5B38B51D Q38822218-A0F76E96-44F7-4EA6-8E86-19594B0B5A0E Q41544409-81E1AE6F-EF72-4941-8A80-E3F8265CCBD5 Q42035666-BA9B0845-AF7C-4002-B691-0E1C9EF19152 Q42135461-36D7A0AB-E6A6-41A8-B847-26DBE500C910 Q42135777-A163DB65-9173-47A9-840E-DD3D58F16489 Q55439694-86D01299-77B6-4B91-BB74-120B7063371E

P2860

Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate

http://www.wikidata.org/entity/Q36245717

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Characterization of synovial a ...... ulation by chondroitin sulfate

@ast

Characterization of synovial a ...... ulation by chondroitin sulfate

@en

type

label

Characterization of synovial a ...... ulation by chondroitin sulfate

@ast

Characterization of synovial a ...... ulation by chondroitin sulfate

@en

prefLabel

Characterization of synovial a ...... ulation by chondroitin sulfate

@ast

Characterization of synovial a ...... ulation by chondroitin sulfate

@en

P1433

Q36245717-0D6280FA-C282-4C9E-9892-6C2D1DAA2E0E

P1476

Q36245717-29EAF44F-9D5A-49A5-89FE-7AEE3770339D

P2093

Q36245717-081A1D51-8EE7-444B-B4A5-04B3A5BFE520

Q36245717-3973CDE4-5FB9-47A1-A503-1040484E8839

Q36245717-6FBF3AAA-203B-4AFA-A0AE-6F51F04DA091

Q36245717-79DF8C9D-8A12-4719-A1B7-72BF0C2252E1

Q36245717-A3BB540A-C12F-48BB-B3EA-44795C94504F

Q36245717-A85D26CE-0E50-4516-B735-AE37BB4369ED

Q36245717-EF12AB63-7BF1-486B-9AE8-8D000BF182C0

P2860

Q36245717-078DBB71-C175-41AE-94BD-C2BBE3265B2D

Q36245717-08896ABA-AC5D-480D-848E-990D4C708027

Q36245717-0EFD3028-C8E3-4AFF-B7F9-08455A8F2B7B

Q36245717-12C4E4BF-7B17-4FC5-85E0-D595DB04D48F

Q36245717-1A9DED93-EF6D-41F7-8B92-B7B386B03CDA

Q36245717-23F7FD0B-0229-499E-B3AA-4FB6A9AB869D

Q36245717-2D5947BE-2FFC-42BA-BD1F-29F9F39D154D

Q36245717-35C180AD-0CCE-4079-8B86-42CA48F2AEC4

Q36245717-3C386E71-F5FD-4A5C-A87A-1557640497F4

Q36245717-3E0CD43C-E98E-45EB-A2D8-26D4EDF26F6C

P2888

Q36245717-CC1CE111-66A4-4A12-B470-9BF0F523FD66

P304

Q36245717-6035D81E-D672-4ED5-BC3A-FF611659F3F8

P31

Q36245717-F23EF60B-6B8D-4195-B059-00966CADF2F9

P356

Q36245717-0F2C58D0-EC9C-43E9-99AD-2DE26A225D6C

P433

Q36245717-D9071C07-744A-4A4A-A072-F8C649C4CDDA

P478

Q36245717-182E7A8C-F53E-42A0-8732-9AFFAA404A61

P50

Q36245717-ABAA0529-FCD4-4065-A7C3-D3C684222DF2

Q36245717-CCC2ADC5-4722-4E7C-99A4-5B2F6EE50027

P577

Q36245717-A0CF1469-442A-43FA-A4C8-5AD6200EBBC2

P5875

Q36245717-98243BE0-3DE8-471A-9058-9ADA9979F829

P698

Q36245717-FA70EC20-146D-4652-B54A-F508D0DD4EBA

P932

Q36245717-924F6678-273C-4A9F-A483-E5E61FD7D97A

P356

P1433

Arthritis Research and Therapy

P1476

Characterization of synovial a ...... ulation by chondroitin sulfate

@en

P2093

Carine Munaut

http://www.w3.org/2001/XMLSchema#string

Cécile Lambert

http://www.w3.org/2001/XMLSchema#string

Eulàlia Montell

http://www.w3.org/2001/XMLSchema#string

Jean-Emile Dubuc

http://www.w3.org/2001/XMLSchema#string

Josep Vergés

http://www.w3.org/2001/XMLSchema#string

Marianne Mathy-Hartert

http://www.w3.org/2001/XMLSchema#string

Yves Henrotin

http://www.w3.org/2001/XMLSchema#string

P2860

TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator

Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis

Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis

Effects of vascular endothelial growth factor (VEGF) and chondroitin sulfate A on human monocytic THP-1 cell migration.

Expression of basic fibroblast growth factor in synovial tissues from patients with rheumatoid arthritis: detection by immunohistological staining and in situ hybridisation

Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.

Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor.

Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis.

P2888

P304

R58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR3771

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Marianne Mathy-Hartert

P577

2012-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221695857

http://www.w3.org/2001/XMLSchema#string

P698

22409996

http://www.w3.org/2001/XMLSchema#string

P932

3446424

http://www.w3.org/2001/XMLSchema#string